Tag Archives: Stem Cells

Stem Cell Transplant Recipients Face Increased Skin Cancer Risks: Study

August 05, 2024 By: Tyler New

Researchers recommended doctors implement rigorous skin cancer surveillance and preventive strategies, especially for those on certain antibiotic medications.
Cord Blood Banking Curative Benefits Often Oversold to Parents: NYT Investigation

July 16, 2024 By: Martha Garcia

Investigations of cord blood banks have found leaky storage bags and bacterial contamination that often makes the preserved stem cells useless.
FDA Warns Consumers About Potential False Advertising Of Regenerative Products Using Stem Cells and Exosomes

July 23, 2020 By: Irvin Jackson
Unapproved Stem Cell and Exosome Products Led To Patient Injuries, FDA Warns

December 11, 2019 By: Russell Maas
Infections From Unapproved, Contaminated Stem Cell Treatments Lead To FDA Warning

December 21, 2018 By: Martha Garcia
One Stem Cell Clinic Shut Down, Another Gets Warning Letter In FDA Crackdown

August 29, 2017 By: Martha Garcia

Lawsuit Alleges Oxbryta Side Effects Resulted in Higher Rate of Vaso-Occlusive Crisis, Other Debilitating Symptoms (Posted 4 days ago)

Illinois man has filed an Oxbryta lawsuit, indicating that the recalled sickle cell disease treatment caused a stroke shortly before Pfizer pulled the drug from the market.

Lawsuit Alleges Suboxone Caused Dental Damage, Erosion and Tooth Decay (Posted 5 days ago)

Kentucky man has filed a lawsuit against Suboxone manufacturers, indicating the opioid treatment film strips were known for years to cause the kind of permanent tooth damage he suffered, long before warning labels were added by the drug manufacturer.

Master Complaint Outlines Allegations in Ozempic, Wegovy, Mounjaro Lawsuits in MDL (Posted 8 days ago)

Plaintiffs pursuing GLP-1 injury lawsuits have filed a Master Complaint outlining common allegations being pursued against Novo Nordisk and Eli Lilly over their diabetes and weight loss drugs, including Ozempic, Wegovy, Mounjaro and others.

Tag Archives: Stem Cells

Stem Cell Transplant Recipients Face Increased Skin Cancer Risks: Study

Cord Blood Banking Curative Benefits Often Oversold to Parents: NYT Investigation

FDA Warns Consumers About Potential False Advertising Of Regenerative Products Using Stem Cells and Exosomes

Unapproved Stem Cell and Exosome Products Led To Patient Injuries, FDA Warns

Infections From Unapproved, Contaminated Stem Cell Treatments Lead To FDA Warning

One Stem Cell Clinic Shut Down, Another Gets Warning Letter In FDA Crackdown

More Top Stories

Review A Case